Baker Bros. Advisors Lp - Dec 31, 2024 SCHEDULE 13G Report for Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL)

Filing Manager
BAKER BROS. ADVISORS LP
Reporting Manager
Baker Bros. Advisors LP
Security
Candel Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
CADL
Shares outstanding
43.9M shares
Disclosed Ownership
2.98M shares
Ownership
6.8%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 04:14 PM
Date of event
Dec 31, 2024
Next filing
May 15, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Baker Bros. Advisors LP 6.8% 2.98M 2.98M 0 /s/ Scott L. Lessing Scott L. Lessing/President, Baker Bros. Advisors (GP) LLC, its general partner
Baker Bros. Advisors (GP) LLC 6.8% 2.98M 2.98M 0 /s/ Scott L. Lessing Scott L. Lessing/President
Julian C. Baker 6.8% 2.98M 2.98M 0 /s/ Julian C. Baker Julian C. Baker
Felix J. Baker 6.8% 2.98M 2.98M 0 /s/ Felix J. Baker Felix J. Baker